デフォルト表紙
市場調査レポート
商品コード
1514928

トラコーマ治療市場：治療別、投与形態別、薬剤クラス別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年予測

Trachoma Treatment Market, By Treatment, By Mode of Administration, By Drug Class, By End-Users, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 375 Pages
納期
2～3営業日
カスタマイズ可能
トラコーマ治療市場：治療別、投与形態別、薬剤クラス別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年06月11日
発行: AnalystView Market Insights
ページ情報: 英文 375 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

レポートハイライト

トラコーマ治療市場規模は2023年に5億4,465万米ドルとなり、2024年から2032年にかけてCAGR 5.8%で拡大

トラコーマ治療市場-市場力学

継続的な政府支援がトラコーマ治療市場の成長を促進

継続的な政府支援は、トラコーマ治療市場の成長を促進する上で極めて重要な役割を果たしています。世界各国の様々な政府が、世界保健機関（WHO）や非政府組織（NGO）などの組織と協力して、トラコーマに効果的に取り組むための包括的なプログラムを実施しています。例えば、WHOのSAFE戦略（手術、抗生物質、顔の清潔さ、環境の改善）は、各国政府から大きな支持と資金援助を受けており、抗生物質の配布、手術介入の提供、流行地域における衛生習慣の促進を支援しています。WHOのSAFE戦略により、2002年以降、トラコーマの有病率は91%減少しました。さらに、政府のイニシアチブには、専用のヘルスケアインフラの確立、ヘルスケア専門家のトレーニング、疾患の流行と治療成果を監視するための継続的なサーベイランスが含まれます。このような政府の持続的な支援は、意識の向上、治療へのアクセスの確保、そして最終的には世界のトラコーマの負担軽減に役立っています。

トラコーマ治療市場-主な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約5.8%のCAGRで毎年成長すると推定されています。

治療セグメンテーションに基づくと、投薬が2023年に最大市場シェアを示すと予測されました。

投与形態別では、経口投与が2023年の主要タイプでした。

薬剤クラス別では、2023年には抗生物質が主要タイプでした。

地域別では、北米が2023年の主要収益源でした。

トラコーマ治療市場-セグメンテーション分析：

世界のトラコーマ治療市場は、治療法、投与方法、薬剤クラス別、エンドユーザー別、地域別に区分されます。

市場は治療に基づいて2つのカテゴリーに分けられる：薬物療法と手術療法です。薬物療法はトラコーマ治療市場における主要な治療手段であり、アジスロマイシンやテトラサイクリンなどの抗生物質が細菌感染と闘うために広く使用されています。手術は、主に瘢痕化や睫毛乱生を伴う進行した症例を対象としており、視力障害への対処や疾患の進行防止において、小規模ながら重要なセグメントを占めています。

市場は投与方法によって4つのカテゴリーに分けられる：経口投与がトラコーマ治療市場を独占しており、細菌感染と闘うための抗生物質の簡便かつ広範囲な投与が可能です。局所治療も普及しており、特に眼球の炎症や不快感などの症状に対応しています。注射療法はあまり一般的ではなく、主に重症例や外科的介入との併用に限られています。

トラコーマ治療市場-地理的洞察

サハラ以南のアフリカ、中東、アジアの一部の流行地域では、トラコーマの有病率が高く、治療ソリューションに対する需要が高まっています。これらの地域の政府や国際機関は、Global Trachoma Mapping ProjectやQueen Elizabeth Diamond Jubilee Trustのようなイニシアチブからの資金援助を受けて、介入プログラムを積極的に実施しています。さらに、北米や欧州のような医療インフラが確立された先進地域は、研究資金や医薬品開発の支援を通じて市場開拓に貢献しています。

トラコーマ治療市場-競合情勢：

ファイザー社、ノバルティス社、メルク社などの製薬会社は、トラコーマ治療のためにアジスロマイシンやテトラサイクリンなどの抗生物質を提供し、医薬品開発と流通において重要な役割を果たしています。さらに、国際トラコーマ・イニシアチブ（ITI）やカーター・センターなどの非営利団体は、各国政府や製薬会社と協力して、トラコーマの感染地域で薬剤の提供、衛生プログラムの実施、手術の実施などを行っています。また、世界保健機関（WHO）や各国の保健省などの政府機関も、トラコーマの制圧・撲滅に向けた政策の策定、資金の提供、取り組みの調整などで大きく貢献しています。製薬会社、非営利団体、政府のこのような協力的なアプローチは、トラコーマに対処するための協調的な努力を強調し、それによって市場の競合情勢を形成しています。

目次

第1章 トラコーマ治療市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 トラコーマ治療の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 トラコーマ治療産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 トラコーマ治療市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 トラコーマ治療市場情勢

  • トラコーマ治療市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 トラコーマ治療市場-治療別

  • 概要
    • 治療別セグメントシェア分析
    • 薬
    • 手術

第8章 トラコーマ治療市場- 投与形態別

  • 概要
    • セグメントシェア分析、投与形態別
    • 経口
    • 局所
    • 注射
    • 外科手術

第9章 トラコーマ治療市場-薬剤クラス別

  • 概要
    • 薬剤クラス別セグメントシェア分析
    • マクロライド
    • テトラサイクリン
    • 眼科用抗感染薬
    • スルホンアミド

第10章 トラコーマ治療市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • 専門クリニック
    • ホームケア
    • その他

第11章 トラコーマ治療市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- トラコーマ治療業界

  • 競争ダッシュボード
  • 企業プロファイル
    • AbbVie Inc.
    • Allergan plc（now part of AbbVie）
    • AstraZeneca plc
    • Bausch Health Companies Inc.
    • Bayer AG
    • Cipla Limited
    • F. Hoffmann-La Roche AG
    • GlaxoSmithKline plc
    • Merck &Co., Inc.
    • Mylan NV（now part of Viatris Inc.）
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Santen Pharmaceutical Co., Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Others

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Trachoma Treatment Market: Treatment Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment
  • TABLE Global Trachoma Treatment Market, by Treatment 2019-2032 (USD Million)
  • TABLE Trachoma Treatment Market: Mode of Administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Mode of Administration
  • TABLE Global Trachoma Treatment Market, by Mode of Administration 2019-2032 (USD Million)
  • TABLE Trachoma Treatment Market: Drug Class Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Trachoma Treatment Market, by Drug Class 2019-2032 (USD Million)
  • TABLE Trachoma Treatment Market: End-Users Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-Users
  • TABLE Global Trachoma Treatment Market, by End-Users 2019-2032 (USD Million)
  • TABLE Trachoma Treatment Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Trachoma Treatment Market, by Region 2019-2032 (USD Million)
  • TABLE North America Trachoma Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Trachoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • TABLE North America Trachoma Treatment Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE North America Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE North America Trachoma Treatment Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Europe Trachoma Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Trachoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • TABLE Europe Trachoma Treatment Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Europe Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Europe Trachoma Treatment Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Asia Pacific Trachoma Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Trachoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • TABLE Asia Pacific Trachoma Treatment Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Asia Pacific Trachoma Treatment Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Latin America Trachoma Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Trachoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • TABLE Latin America Trachoma Treatment Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Latin America Trachoma Treatment Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Trachoma Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Trachoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Trachoma Treatment Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Trachoma Treatment Market, by End-Users, 2019-2032 (USD Million)

List of Figures

  • FIGURE Trachoma Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Treatment segment market share analysis, 2023 & 2032
  • FIGURE Treatment segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mode of Administration segment market share analysis, 2023 & 2032
  • FIGURE Mode of Administration segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Drug Class segment market share analysis, 2023 & 2032
  • FIGURE Drug Class segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-Users segment market share analysis, 2023 & 2032
  • FIGURE End-Users segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Trachoma Treatment Market share and leading players, 2023
  • FIGURE Europe Trachoma Treatment Market share and leading players, 2023
  • FIGURE Asia Pacific Trachoma Treatment Market share and leading players, 2023
  • FIGURE Latin America Trachoma Treatment Market share and leading players, 2023
  • FIGURE Middle East and Africa Trachoma Treatment Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Trachoma Treatment Market share analysis by country, 2023
  • FIGURE Germany Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Trachoma Treatment Market share analysis by country, 2023
  • FIGURE India Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Trachoma Treatment Market share analysis by country, 2023
  • FIGURE Brazil Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Trachoma Treatment Market share analysis by country, 2023
  • FIGURE Saudi Arabia Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Trachoma Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3050

REPORT HIGHLIGHT

Trachoma Treatment Market size was valued at USD 544.65 million in 2023, expanding at a CAGR of 5.8% from 2024 to 2032.

The Trachoma Treatment Market comprises therapies and interventions aimed at combating trachoma, an infectious eye disease caused by the bacterium Chlamydia trachomatis, and is poised for growth driven by initiatives like the WHO's SAFE strategy (Surgery, Antibiotics, Facial cleanliness, and Environmental improvements), increasing awareness campaigns, and enhanced access to healthcare services in endemic regions. However, challenges such as limited access to healthcare in rural areas, inadequate infrastructure, and the high cost of treatment pose restraints. Market opportunities lie in the development of innovative treatments, strategic partnerships with NGOs and government organizations, and the implementation of preventative measures to reduce disease prevalence and improve overall eye health in affected populations.

Trachoma Treatment Market- Market Dynamics

Continuous Government Support Propel Growth in the Trachoma Treatment Market

Continuous government support is playing a pivotal role in propelling the growth of the Trachoma Treatment Market. Various governments worldwide, in collaboration with organizations like the World Health Organization (WHO) and non-governmental organizations (NGOs), are implementing comprehensive programs to tackle trachoma effectively. For instance, the WHO's SAFE strategy (Surgery, Antibiotics, Facial cleanliness, and Environmental improvements) has received significant endorsement and funding from governments, aiding in the distribution of antibiotics, provision of surgical interventions, and promotion of hygiene practices in endemic regions. The WHO's SAFE strategy has reduced trachoma prevalence by 91% since 2002. Additionally, government initiatives include the establishment of dedicated healthcare infrastructure, training of healthcare professionals, and ongoing surveillance to monitor disease prevalence and treatment outcomes. This sustained governmental support is instrumental in driving awareness, ensuring access to treatment, and ultimately reducing the burden of trachoma worldwide.

Trachoma Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.8% over the forecast period (2024-2032)

Based on Treatment segmentation, Medication was predicted to show maximum market share in the year 2023

Based on Mode of Administration segmentation, Oral administration was the leading type in 2023

Based on Drug Class segmentation, Antibiotics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Trachoma Treatment Market- Segmentation Analysis:

The Global Trachoma Treatment Market is segmented based on Treatment, Mode of Administration, Drug Class, End-Users, and Region.

The market is divided into two categories based on Treatment: Medication, and Surgery. Medication is the predominant treatment modality in the Trachoma Treatment Market, with antibiotics like azithromycin and tetracycline being widely used to combat bacterial infection. Surgery, primarily targeting advanced cases with scarring and trichiasis, represents a smaller yet crucial segment in addressing vision impairment and preventing disease progression.

The market is divided into four categories based on the Mode of Administration: Oral administration dominates the Trachoma Treatment Market, facilitating easy and widespread delivery of antibiotics to combat bacterial infection. Topical treatments are also prevalent, particularly for addressing symptoms like ocular inflammation and discomfort. Injectable therapies are less common, primarily reserved for severe cases or in conjunction with surgical interventions.

Trachoma Treatment Market- Geographical Insights

Endemic areas in sub-Saharan Africa, the Middle East, and parts of Asia exhibit a higher prevalence of trachoma, driving demand for treatment solutions. Governments and international organizations in these regions are actively implementing intervention programs, supported by funding from initiatives like the Global Trachoma Mapping Project and the Queen Elizabeth Diamond Jubilee Trust. In addition, developed regions with established healthcare infrastructure, such as North America and Europe, contribute to market growth through research funding and support for drug development.

Trachoma Treatment Market- Competitive Landscape:

Pharmaceutical companies such as Pfizer Inc., Novartis AG, and Merck & Co., Inc., play a crucial role in drug development and distribution, offering antibiotics like azithromycin and tetracycline for trachoma treatment. Additionally, nonprofit organizations such as the International Trachoma Initiative (ITI) and the Carter Center work in collaboration with governments and pharmaceutical companies to provide medication, implement hygiene programs, and conduct surgeries in affected regions. Governmental organizations like the World Health Organization (WHO) and national health ministries also contribute significantly by formulating policies, providing funding, and coordinating efforts to control and eliminate trachoma. This collaborative approach among pharmaceutical companies, nonprofit organizations, and governments underscores the concerted effort to address trachoma, thereby shaping the competitive landscape of the market.

Recent Developments:

In June 2022, Pfizer pledged to prolong its antibiotic donation initiative until 2025, ensuring the continued availability of Zithromax to aid endemic countries in meeting their targets for trachoma elimination. This commitment strengthens Pfizer's longstanding partnership with ITI and the global health community.

In July 2023, Vision Spring, Live Well, and the Council of Churches Zambia unveiled a new initiative in Zambia. The program is expected to cater to around 75% of participants requiring vision correction, encompassing treatments for conditions such as trachoma and cataracts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TRACHOMA TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AbbVie Inc.

Allergan plc (now part of AbbVie)

AstraZeneca plc

Bausch Health Companies Inc.

Bayer AG

Cipla Limited

F. Hoffmann-La Roche AG

GlaxoSmithKline plc

Merck & Co., Inc.

Mylan N.V. (now part of Viatris Inc.)

Novartis AG

Pfizer Inc.

Sanofi S.A.

Santen Pharmaceutical Co., Ltd.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Others

GLOBAL TRACHOMA TREATMENT MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Medication
  • Surgery

GLOBAL TRACHOMA TREATMENT MARKET, BY MODE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Topical
  • Injectable
  • Surgical

GLOBAL TRACHOMA TREATMENT MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2019 - 2032

  • Macrolides
  • Tetracycline
  • Ophthalmic anti-infective
  • Sulfonamides

GLOBAL TRACHOMA TREATMENT MARKET, BY END-USERS- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

GLOBAL TRACHOMA TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Trachoma Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Trachoma Treatment Market Snippet by Treatment
    • 2.1.2. Trachoma Treatment Market Snippet by Mode of Administration
    • 2.1.3. Trachoma Treatment Market Snippet by Drug Class
    • 2.1.4. Trachoma Treatment Market Snippet by End-Users
    • 2.1.5. Trachoma Treatment Market Snippet by Country
    • 2.1.6. Trachoma Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Trachoma Treatment Key Market Trends

  • 3.1. Trachoma Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Trachoma Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Trachoma Treatment Market Opportunities
  • 3.4. Trachoma Treatment Market Future Trends

4. Trachoma Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Trachoma Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Trachoma Treatment Market Landscape

  • 6.1. Trachoma Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Trachoma Treatment Market - By Treatment

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 7.1.2. Medication
    • 7.1.3. Surgery

8. Trachoma Treatment Market - By Mode of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Mode of Administration, 2023 & 2032 (%)
    • 8.1.2. Oral
    • 8.1.3. Topical
    • 8.1.4. Injectable
    • 8.1.5. Surgical

9. Trachoma Treatment Market - By Drug Class

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Drug Class, 2023 & 2032 (%)
    • 9.1.2. Macrolides
    • 9.1.3. Tetracycline
    • 9.1.4. Ophthalmic anti-infective
    • 9.1.5. Sulfonamides

10. Trachoma Treatment Market - By End-Users

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-Users, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Specialty Clinics
    • 10.1.4. Homecare
    • 10.1.5. Others

11. Trachoma Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Trachoma Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Trachoma Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Trachoma Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Trachoma Treatment Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Trachoma Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Trachoma Treatment Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. AbbVie Inc.
    • 12.2.2. Allergan plc (now part of AbbVie)
    • 12.2.3. AstraZeneca plc
    • 12.2.4. Bausch Health Companies Inc.
    • 12.2.5. Bayer AG
    • 12.2.6. Cipla Limited
    • 12.2.7. F. Hoffmann-La Roche AG
    • 12.2.8. GlaxoSmithKline plc
    • 12.2.9. Merck & Co., Inc.
    • 12.2.10. Mylan N.V. (now part of Viatris Inc.)
    • 12.2.11. Novartis AG
    • 12.2.12. Pfizer Inc.
    • 12.2.13. Sanofi S.A.
    • 12.2.14. Santen Pharmaceutical Co., Ltd.
    • 12.2.15. Sun Pharmaceutical Industries Ltd.
    • 12.2.16. Teva Pharmaceutical Industries Ltd.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us